Abstract
Post-Traumatic Stress Disorder (PTSD) presents a significant challenge in mental health treatment, affecting millions of individuals worldwide. While conventional therapies such as cognitive behavioral therapy and selective serotonin reuptake inhibitors have shown some efficacy, a considerable portion of patients remains resistant to treatment. Recent clinical trials have demonstrated the safety and efficacy of MDMA-assisted psychotherapy leading to the Food and Drug Administration's designation of Breakthrough Therapy status and the submission of a New Drug Application. Despite promising results, challenges such as stigma, regulatory barriers, and therapist training remain. However, the need for innovative treatments for PTSD necessitates further exploration of MDMA-assisted psychotherapy's therapeutic potential.
Recommended Citation
Howard, H. Illuminating the path to healing: unveiling the potential of MDMA-assisted therapy for PTSD. BUHealth. 2024; 2(1). https://digitalcommons.butler.edu/buhealth/vol2/iss1/12.
Infographic